NOVONIX Limited (NASDAQ:NVX - Get Free Report) saw a significant decrease in short interest in February. As of February 28th, there was short interest totalling 353,800 shares, a decrease of 29.8% from the February 13th total of 503,700 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 212,200 shares, the short-interest ratio is currently 1.7 days.
NOVONIX Stock Up 0.4 %
Shares of NASDAQ NVX traded up $0.01 during trading on Thursday, hitting $1.18. The company had a trading volume of 35,210 shares, compared to its average volume of 101,758. NOVONIX has a 52 week low of $0.97 and a 52 week high of $3.10. The business's 50-day moving average is $1.40 and its 200 day moving average is $1.70. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.15 and a quick ratio of 5.94.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of NVX. Two Sigma Securities LLC bought a new position in shares of NOVONIX in the fourth quarter valued at $28,000. Jackson Hole Capital Partners LLC bought a new position in shares of NOVONIX in the fourth quarter valued at $45,000. Jane Street Group LLC increased its holdings in shares of NOVONIX by 103.5% in the third quarter. Jane Street Group LLC now owns 34,495 shares of the company's stock valued at $63,000 after buying an additional 17,541 shares in the last quarter. Finally, Quinn Opportunity Partners LLC bought a new position in shares of NOVONIX in the fourth quarter valued at $99,000. Institutional investors own 0.06% of the company's stock.
NOVONIX Company Profile
(
Get Free Report)
NOVONIX Limited provides battery materials and development technology for battery manufacturers, materials companies, automotive original equipment manufacturers (OEMs), and consumer electronics manufacturers in North America, Asia, Australia, and Europe. It operates through Battery Materials and Battery Technology segments.
See Also
Before you consider NOVONIX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOVONIX wasn't on the list.
While NOVONIX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
